SecBot SecBot

OSTX

OS Therapies Inc
NYSE· Pharmaceutical Preparations· Inc. DE· CIK 0001795091 Biotech & Drug Discovery
$1.25 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $1.25
Market cap
$65.0M
Micro cap
Median target
🔒 Subscribers only
1 year
−33.9%
from $1.89 · Oct 24
30 days
−24.7%
from $1.66
52-week range
$1.16–2.24
−44% from high · low Feb 12
Avg volume 20D
716.1K
Oct 6 spike 6.01M
Short interest
2.60M
≈5.6% of shares · +22.7%
Days to cover
3.9
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 2 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 4/4 ·Next Earnings date, Nov 13, 2026
Strongest BULLISH OS Therapies completed an initial closing of a warrant exercise inducement and exchange offer, receiving…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q2 2026: 7 added (0 new), 3 trimmed or exited.

  • Short sellersBUILDING

    Short interest +22.7% to 2.60M shares. 3.9 days to cover, ≈5.6% of shares.

  • TrendDOWNTREND

    22% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCADD777,651$1.5M
BlackRock, Inc.DOUBLED242,479$460.7K
VANGUARD FIDUCIARY TRUST COADD174,132$330.9K
STATE STREET CORPADD120,100$228.2K
HighTower Advisors, LLCDOUBLED85,550$162.5K
STIFEL FINANCIAL CORPADD27,900$53.0K
JANE STREET GROUP, LLCTRIM26,999$51.3K
SUSQUEHANNA INTERNATIONAL GROUP, LLPNEAR_EXIT13,532$25.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jul 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Jul 9, 2026Roth Capital
INITIATE
INITIATEBuy
May 19, 2026Lake Street
MAINTAIN
MAINTAINBuy
Apr 30, 2026D. Boral Capital
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jan 22, 2026
PETIT ROBERT
See Remarks
AWARD100,000 sh
Jan 22, 2026
Jarry Olivier Roger
Director
AWARD50,000 sh
Jan 22, 2026
Ciccio John
Director
AWARD50,000 sh
Jan 22, 2026
McKean-Dieser Avril Suzette
Director
AWARD50,000 sh
Jan 22, 2026
Search Theodore F.
Director
AWARD50,000 sh
Jan 22, 2026
Romness Paul A.
President and CEO
AWARD1,000,000 sh
Jan 22, 2026
Galzahr Karim
Director
AWARD50,000 sh
Jan 22, 2026
Acevedo Christopher P.
Chief Financial Officer
AWARD100,000 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
2,595,455
shares short
+22.7%
vs prior settlement
3.9
days to cover
≈5.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 19, 2026 SEC
OS Therapies completed an initial closing of a warrant exercise inducement and exchange offer, receiving approximately…
8-K — Impact 6/10
Oct 5, 2026 SEC
Francis Knuettel II, the newly appointed Chief Financial Officer of OS Therapies Inc, filed a Form 3 initial statement…
3 — Impact 2/10
Oct 5, 2026 SEC
OS Therapies appointed Frank Knuettel II as CFO and Kerry Clem as CCO, replacing outgoing CFO Christopher Acevedo. The…
8-K — Impact 5/10
Sep 30, 2026 Short interest report
Short Interest: OSTX up 23% to 2.6M shares
Settlement 2026-09-30 | Days to cover: 3.88 | ≈5.59% of shares outstanding (est.)
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
777,651 shares ($1.5M)
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
242,479 shares ($460.7K)
Jan 22, 2026 Insider
PETIT ROBERT was granted 100,000 shares
See Remarks
Jan 22, 2026 Insider
Jarry Olivier Roger was granted 50,000 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 13, 2026
Earnings date
🔒 Fresh data — subscribers only
Recent
Sep 30, 2026
Short interest
Short Interest: OSTX up 23% to 2.6M shares
Settlement 2026-09-30 | Days to cover: 3.88 | ≈5.59% of shares outstanding (est.)
Sep 15, 2026
Short interest
Short Interest: OSTX down 23% to 2.1M shares
Settlement 2026-09-15 | Days to cover: 2.52 | ≈4.55% of shares outstanding (est.)
Aug 13, 2026
Earnings date
OSTX Q2 2026 Earnings Scheduled — 2026-08-13
Jun 15, 2026
Short interest
Short Interest: OSTX up 23% to 2.0M shares
Settlement 2026-06-15 | Days to cover: 3.16 | ≈4.56% of shares outstanding (est.)
May 15, 2026
Earnings date
OSTX Q1 2026 Earnings Scheduled — 2026-05-15

SecBot reports

4 filings · 2 bullish · 0 bearish · 2 neutral
All OSTX filing & press-release reports (4)